2024 Q2 Form 10-Q Financial Statement

#000165495424006315 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $13.20M $12.86M
YoY Change 17.68% 19.4%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $266.4K $258.2K
YoY Change -0.22% -6.67%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $5.096M $4.502M
YoY Change 73.01% 100.35%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.271M $3.378M
YoY Change -17.46% -17.93%
Income Tax $542.4K $554.9K
% Of Pretax Income 16.58% 16.43%
Net Earnings $2.728M $2.823M
YoY Change -14.65% -15.45%
Net Earnings / Revenue 20.67% 21.95%
Basic Earnings Per Share $0.49 $0.51
Diluted Earnings Per Share $0.49 $0.51
COMMON SHARES
Basic Shares Outstanding 5.535M shares 5.514M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $18.43M $15.92M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $12.49M $12.38M
YoY Change -1.28% -3.88%
Goodwill $11.57M $11.57M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.100B $1.107B
YoY Change 6.65% 7.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.609M $4.943M
YoY Change 40.26% -15.85%
Accrued Expenses $480.00 $395.0K
YoY Change -99.91% -34.71%
Deferred Revenue
YoY Change
Short-Term Debt $76.34K -$58.03M
YoY Change -99.78% -252.49%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.686M -$52.70M
YoY Change -77.23% -218.32%
LONG-TERM LIABILITIES
Long-Term Debt $12.89M $16.26M
YoY Change -21.51% -1.34%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $12.89M $16.26M
YoY Change -21.51% -1.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.686M -$52.70M
Total Long-Term Liabilities $12.89M $16.26M
Total Liabilities $1.009B $1.018B
YoY Change 6.07% 7.03%
SHAREHOLDERS EQUITY
Retained Earnings $57.14M $55.72M
YoY Change 14.55% 16.15%
Common Stock $14.41M $14.36M
YoY Change 1.44% 1.41%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.623M $2.623M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $91.33M $89.40M
YoY Change
Total Liabilities & Shareholders Equity $1.100B $1.107B
YoY Change 6.65% 7.43%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $2.728M $2.823M
YoY Change -14.65% -15.45%
Depreciation, Depletion And Amortization $266.4K $258.2K
YoY Change -0.22% -6.67%
Cash From Operating Activities $4.537M $1.695M
YoY Change 112.36% -52.1%
INVESTING ACTIVITIES
Capital Expenditures $430.8K $292.7K
YoY Change 352.74% 84.09%
Acquisitions
YoY Change
Other Investing Activities $8.926M -$13.22M
YoY Change -147.05% 106.21%
Cash From Investing Activities $8.495M -$13.52M
YoY Change -144.56% 105.68%
FINANCING ACTIVITIES
Cash Dividend Paid $905.9K
YoY Change -2.89%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.52M $7.303M
YoY Change 665.47% -123.97%
NET CHANGE
Cash From Operating Activities 4.537M $1.695M
Cash From Investing Activities 8.495M -$13.52M
Cash From Financing Activities -10.52M $7.303M
Net Change In Cash 2.513M -$4.518M
YoY Change -113.73% -86.51%
FREE CASH FLOW
Cash From Operating Activities $4.537M $1.695M
Capital Expenditures $430.8K $292.7K
Free Cash Flow $4.106M $1.402M
YoY Change 101.16% -58.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000718413
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 cmtv Time Deposits Over
TimeDepositsOver
250000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
15 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
15 shares
CY2023Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
100000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
210101 shares
CY2023Q4 cmtv Financing Receivable Recorded Investment30 To89 Days Past Due
FinancingReceivableRecordedInvestment30To89DaysPastDue
2549585 usd
CY2024Q1 cmtv Financing Receivable Recorded Investment30 To89 Days Past Due
FinancingReceivableRecordedInvestment30To89DaysPastDue
2323006 usd
CY2023Q4 cmtv Financing Receivable Recorded Investment90 Days Or More Past Due
FinancingReceivableRecordedInvestment90DaysOrMorePastDue
4685234 usd
CY2024Q1 cmtv Financing Receivable Recorded Investment90 Days Or More Past Due
FinancingReceivableRecordedInvestment90DaysOrMorePastDue
4497060 usd
CY2023Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
485174 usd
CY2024Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
786999 usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-16435
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Community Bancorp./VT
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VT
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0284070
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4811 US Route 5
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Derby
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VT
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
05829
CY2024Q1 dei City Area Code
CityAreaCode
802
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
334-7915
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5534819 shares
CY2024Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
11236615 usd
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
15001122 usd
CY2024Q1 us-gaap Federal Funds Sold
FederalFundsSold
4679782 usd
CY2023Q4 us-gaap Federal Funds Sold
FederalFundsSold
5433391 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15916397 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20434513 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
180577058 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
190706019 usd
CY2024Q1 cmtv Restricted Equity Securities At Cost
RestrictedEquitySecuritiesAtCost
1977350 usd
CY2023Q4 cmtv Restricted Equity Securities At Cost
RestrictedEquitySecuritiesAtCost
1642350 usd
CY2024Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
441000 usd
CY2023Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
866352361 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
845429854 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
10027768 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
9842725 usd
CY2024Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
589095 usd
CY2023Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
573169 usd
CY2024Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
856913688 usd
CY2023Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
836160298 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12375501 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12371371 usd
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
4852826 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
4246798 usd
CY2024Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5252858 usd
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5232703 usd
CY2024Q1 us-gaap Goodwill
Goodwill
11574269 usd
CY2023Q4 us-gaap Goodwill
Goodwill
11574269 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
17238023 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
16976613 usd
CY2024Q1 us-gaap Assets
Assets
1107118970 usd
CY2023Q4 us-gaap Assets
Assets
1099344934 usd
CY2024Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
185831108 usd
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
202969957 usd
CY2024Q1 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
291012736 usd
CY2023Q4 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
297030893 usd
CY2024Q1 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
120044494 usd
CY2023Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
121375419 usd
CY2024Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
150718352 usd
CY2023Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
151570686 usd
CY2024Q1 cmtv Time Deposits Over
TimeDepositsOver
250000 usd
CY2024Q1 us-gaap Time Deposits
TimeDeposits
30182543 usd
CY2023Q4 us-gaap Time Deposits
TimeDeposits
24676853 usd
CY2024Q1 cmtv Other Time Deposits
OtherTimeDeposits
105965451 usd
CY2023Q4 cmtv Other Time Deposits
OtherTimeDeposits
99343974 usd
CY2024Q1 us-gaap Deposits
Deposits
883754684 usd
CY2023Q4 us-gaap Deposits
Deposits
896967782 usd
CY2024Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
27166247 usd
CY2023Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
36255920 usd
CY2024Q1 cmtv Federal Funds Purchased And Other Borrowed Funds
FederalFundsPurchasedAndOtherBorrowedFunds
85200000 usd
CY2023Q4 cmtv Federal Funds Purchased And Other Borrowed Funds
FederalFundsPurchasedAndOtherBorrowedFunds
54600000 usd
CY2024Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
12887000 usd
CY2023Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
12887000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
8707076 usd
CY2023Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9605418 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1017715007 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1010316120 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15 shares
CY2024Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
100000 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
1500000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1500000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5745307 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5724151 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
14363268 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
14310378 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37882139 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37574578 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
55720936 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
54198230 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17439603 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15931595 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
210101 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2622777 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2622777 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
89403963 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
89028814 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1107118970 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1099344934 usd
CY2024Q1 cmtv Book Value Per Share On Common Shares Outstanding
BookValuePerShareOnCommonSharesOutstanding
15.88
CY2023Q4 cmtv Book Value Per Share On Common Shares Outstanding
BookValuePerShareOnCommonSharesOutstanding
15.87
CY2024Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
11678217 usd
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
9376025 usd
CY2024Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
972349 usd
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
943478 usd
CY2024Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
80411 usd
CY2023Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
90658 usd
CY2024Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
42384 usd
CY2023Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
30653 usd
CY2024Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
85933 usd
CY2023Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
329411 usd
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
12859294 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10770225 usd
CY2024Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
3080172 usd
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1844747 usd
CY2024Q1 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
945816 usd
CY2023Q1 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
24520 usd
CY2024Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
198892 usd
CY2023Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
132128 usd
CY2024Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
276769 usd
CY2023Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
245465 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
4501649 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2246860 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8357645 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8523365 usd
CY2024Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
313579 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
286526 usd
CY2024Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8044066 usd
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8236839 usd
CY2024Q1 cmtv Service Fee Income
ServiceFeeIncome
897920 usd
CY2023Q1 cmtv Service Fee Income
ServiceFeeIncome
880288 usd
CY2024Q1 us-gaap Interest And Fee Income Loans Held For Sale Mortgages
InterestAndFeeIncomeLoansHeldForSaleMortgages
79104 usd
CY2023Q1 us-gaap Interest And Fee Income Loans Held For Sale Mortgages
InterestAndFeeIncomeLoansHeldForSaleMortgages
107535 usd
CY2024Q1 us-gaap Interest And Fee Income Other Loans
InterestAndFeeIncomeOtherLoans
254601 usd
CY2023Q1 us-gaap Interest And Fee Income Other Loans
InterestAndFeeIncomeOtherLoans
428572 usd
CY2024Q1 us-gaap Other Income
OtherIncome
402282 usd
CY2023Q1 us-gaap Other Income
OtherIncome
342382 usd
CY2024Q1 us-gaap Noninterest Income
NoninterestIncome
1633907 usd
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
1758777 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
2458000 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
2288760 usd
CY2024Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
899236 usd
CY2023Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
754270 usd
CY2024Q1 us-gaap Occupancy Net
OccupancyNet
722503 usd
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
770986 usd
CY2024Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2220405 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2065686 usd
CY2024Q1 us-gaap Noninterest Expense
NoninterestExpense
6300144 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
5879702 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3377829 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4115914 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
554928 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
777153 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
2822901 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3338761 usd
CY2024Q1 cmtv Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
0.51
CY2023Q1 cmtv Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
0.61
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5521509 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5444040 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
2822901 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3338761 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1908870 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3383314 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
400862 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-710496 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1508008 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2672818 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1314893 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6011579 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
89028814 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
360451 usd
CY2024Q1 cmtv Dividend Declared Common Stock
DividendDeclaredCommonStock
-1268320 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
31875 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
2822901 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1508008 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
89403963 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
75176363 usd
CY2023Q1 cmtv Cumulative Change In Accounting Principle
CumulativeChangeInAccountingPrinciple
-549113 usd
CY2023Q1 cmtv Balance As Adjusted For Change In Accounting Principle
BalanceAsAdjustedForChangeInAccountingPrinciple
74627250 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
319877 usd
CY2023Q1 cmtv Dividend Declared Common Stock
DividendDeclaredCommonStock
-1250794 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
28125 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3338761 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2672818 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
79679787 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
2822901 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
3338761 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
258219 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
276656 usd
CY2024Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
313579 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
286526 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
165056 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-68835 usd
CY2024Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
-12092 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
-29331 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13981 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q1 cmtv Income Loss From Cfs Partners
IncomeLossFromCFSPartners
-294327 usd
CY2023Q1 cmtv Income Loss From Cfs Partners
IncomeLossFromCFSPartners
-252051 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
53550 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
66815 usd
CY2024Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
690092 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
1637381 usd
CY2024Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
1119000 usd
CY2023Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
1608050 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
240670 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
778860 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-606028 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
103159 usd
CY2024Q1 cmtv Servicing Asset At Amortized Values Period Increase Decrease
ServicingAssetAtAmortizedValuesPeriodIncreaseDecrease
22276 usd
CY2023Q1 cmtv Servicing Asset At Amortized Values Period Increase Decrease
ServicingAssetAtAmortizedValuesPeriodIncreaseDecrease
23370 usd
CY2024Q1 cmtv Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
44281 usd
CY2023Q1 cmtv Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
50321 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-48495 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-53751 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-143424 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-72609 usd
CY2024Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
-20155 usd
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
-19615 usd
CY2024Q1 us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
149202 usd
CY2023Q1 us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
67128 usd
CY2024Q1 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
-15926 usd
CY2023Q1 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
-16336 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
200624 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-2485 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1069838 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1040367 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
77844 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
73186 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1695028 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3538733 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
8166541 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3555278 usd
CY2024Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
1424800 usd
CY2023Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
67800 usd
CY2024Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
1759800 usd
CY2023Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
92600 usd
CY2024Q1 cmtv Investments In Limited Liability Entities
InvestmentsInLimitedLiabilityEntities
0 usd
CY2023Q1 cmtv Investments In Limited Liability Entities
InvestmentsInLimitedLiabilityEntities
1000 usd
CY2024Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
-21073009 usd
CY2023Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
-10074935 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
292650 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
158971 usd
CY2024Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
17746 usd
CY2023Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
132860 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13516372 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6571568 usd
CY2024Q1 us-gaap Increase Decrease In Demand Deposits
IncreaseDecreaseInDemandDeposits
-23157006 usd
CY2023Q1 us-gaap Increase Decrease In Demand Deposits
IncreaseDecreaseInDemandDeposits
-29855106 usd
CY2024Q1 us-gaap Increase Decrease In Savings Deposits
IncreaseDecreaseInSavingsDeposits
-2183259 usd
CY2023Q1 us-gaap Increase Decrease In Savings Deposits
IncreaseDecreaseInSavingsDeposits
-8183145 usd
CY2024Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
12127167 usd
CY2023Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
3611070 usd
CY2024Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-9089673 usd
CY2023Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
4980207 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
25600000 usd
CY2023Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2024Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
56229 usd
CY2023Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
54493 usd
CY2024Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
31875 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
28125 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
905897 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
932901 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7303228 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30462493 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4518116 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-33495328 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20434513 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71140328 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15916397 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37645000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
4301025 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2249345 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-1908870 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
3383314 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1268320 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1250794 usd
CY2024Q1 cmtv Increase In Dividends Payable Attributable To Dividends Declared
IncreaseInDividendsPayableAttributableToDividendsDeclared
-1972 usd
CY2023Q1 cmtv Increase In Dividends Payable Attributable To Dividends Declared
IncreaseInDividendsPayableAttributableToDividendsDeclared
1984 usd
CY2024Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
360451 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
319877 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
905897 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
932901 usd
CY2024Q1 cmtv Purchased Commercial Loans
PurchasedCommercialLoans
5452239 usd
CY2024Q1 cmtv Purchased Consumer Loans
PurchasedConsumerLoans
4755125 usd
CY2023Q4 cmtv Purchased Commercial Loans
PurchasedCommercialLoans
4863263 usd
CY2024Q1 cmtv Less Dividends To Preferred Shareholders
LessDividendsToPreferredShareholders
31875 usd
CY2023Q1 cmtv Less Dividends To Preferred Shareholders
LessDividendsToPreferredShareholders
28125 usd
CY2023Q4 cmtv Purchased Consumer Loans
PurchasedConsumerLoans
5705659 usd
CY2024Q1 cmtv Nonaccrual With No Acl
NonaccrualWithNoAcl
6385101 usd
CY2023Q4 cmtv Nonaccrual With No Acl
NonaccrualWithNoAcl
6955046 usd

Files In Submission

Name View Source Status
0001654954-24-006315-index-headers.html Edgar Link pending
0001654954-24-006315-index.html Edgar Link pending
0001654954-24-006315.txt Edgar Link pending
0001654954-24-006315-xbrl.zip Edgar Link pending
cmtv-20240331.xsd Edgar Link pending
cmtv_10q.htm Edgar Link pending
cmtv_10qimg1.jpg Edgar Link pending
cmtv_ex311.htm Edgar Link pending
cmtv_ex312.htm Edgar Link pending
cmtv_ex321.htm Edgar Link pending
cmtv_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
cmtv-20240331_def.xml Edgar Link unprocessable
cmtv-20240331_lab.xml Edgar Link unprocessable
cmtv-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cmtv_10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cmtv-20240331_cal.xml Edgar Link unprocessable